Science Explorer Interactive view Map
Institution · Düsseldorf · Germany

Michalski Huettermann and Partner

Research works
51
▼ 54% vs 2013–17
Citations
270
5.3 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Michalski Huettermann and Partner is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.22× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 0.12× its world share, 0 worksImmunology and Micro…Computer Science: 0.58× its world share, 0 worksComputer ScienceEngineering: 0.60× its world share, 1 worksEngineeringHealth Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 0.68× its world share, 1 worksMedicineBusiness, Management and Accounting: 8.43× its world share, 2 worksBusiness, Management…Decision Sciences: 4.69× its world share, 0 worksDecision SciencesSocial Sciences: 0.12× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Business, Management and Accounting, 8.4×. Every wedge is a field page.

Which keywords describe research at Michalski Huettermann and Partner?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Innovation, Emerging Markets, Entrepreneurship, Medical Ethics, Patient Rights, Genome Engineering and RNA-Guided.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Innovation6▲ 13×4 topics
  2. Monoclonal Antibodies6▲ 83×3 topics
  3. Emerging Markets4▲ 169×2 topics
  4. Entrepreneurship4▲ 31×2 topics
  5. Medical Ethics4▲ 40×1 topic
  6. Patient Rights4▲ 72×1 topic
  7. Genome Engineering4▲ 117×1 topic
  8. RNA-Guided4▲ 117×1 topic
  9. Biopharmaceuticals3▲ 93×2 topics
  10. Immunogenicity3▲ 124×2 topics
  11. Glycosylation3▲ 28×2 topics
  12. Intellectual Property Rights3▲ 133×1 topic
  13. Patent Analysis3▲ 361×1 topic
  14. Bioanalytical Methods3▲ 403×1 topic
  15. Biosimilars3▲ 403×1 topic
  16. Therapeutic Antibodies3▲ 46×2 topics
  17. Antibody Engineering3▲ 55×1 topic
  18. Ethical Issues3▲ 57×4 topics
  19. Fc Receptors3▲ 55×1 topic
  20. Bottom of the Pyramid2▲ 140×1 topic
  21. Frugal Innovation2▲ 140×1 topic
  22. Public Health2▲ 3.1×4 topics
  23. Global Collaboration2▲ 100×1 topic
  24. Health Biotechnology2▲ 216×1 topic
  25. Regulatory Challenges2▲ 49×2 topics
  26. Clinical Trials2▲ 5.2×2 topics
  27. CAR T Cells2▲ 68×1 topic
  28. Chimeric Antigen Receptor2▲ 68×1 topic
  29. Human Rights2▲ 3.4×2 topics
  30. Patient Safety2▲ 24×1 topic
  31. Stem Cell Regulation2▲ 127×1 topic
  32. Chronic Diseases1▲ 9.3×2 topics
  33. Corporate Governance1▲ 4.8×4 topics
  34. Governance1▲ 8.7×2 topics
  35. Vaccine1▲ 6.2×2 topics
  36. Data Protection1▲ 125×2 topics
  37. Legal Methodology1▲ 80×1 topic
  38. Party Competition1▲ 147×1 topic
  39. Bildungsungleichheit1▲ 69×1 topic
  40. Coaching1▲ 102×1 topic

Which research topics does Michalski Huettermann and Partner publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, Innovation and Socioeconomic Development, SARS-CoV-2 and COVID-19 Research and RNA Interference and Gene Delivery.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 2 works
  2. 2 Innovation and Socioeconomic Development Business and International Management 2 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  4. 4 RNA Interference and Gene Delivery Molecular Biology 0 works
  5. 5 Academic Publishing and Open Access Information Systems and Management 0 works
  6. 6 COVID-19 Digital Contact Tracing Information Systems 0 works
  7. 7 Genetics, Aging, and Longevity in Model Organisms Aging 0 works
  8. 8 Flexible and Reconfigurable Manufacturing Systems Industrial and Manufacturing Engineering 0 works
  9. 9 Microfluidic and Bio-sensing Technologies Biomedical Engineering 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.6%not open70.4%

World: 28% of research is openly available.

with international co-authors9.7%domestic only90.3%

World: 19% is written across borders.

How has Michalski Huettermann and Partner's research output changed?

Output in 2018–2022 was 54% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Düsseldorf

All research institutions in Düsseldorf

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.